nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—neck—thyroid cancer	0.0797	0.147	CbGeAlD
Mimosine—SHMT1—saliva-secreting gland—thyroid cancer	0.0671	0.123	CbGeAlD
Mimosine—CCL2—Oncostatin M Signaling Pathway—OSMR—thyroid cancer	0.0665	0.146	CbGpPWpGaD
Mimosine—TYR—head—thyroid cancer	0.0586	0.108	CbGeAlD
Mimosine—SHMT1—trachea—thyroid cancer	0.0518	0.0951	CbGeAlD
Mimosine—CCL2—trachea—thyroid cancer	0.048	0.0882	CbGeAlD
Mimosine—TYR—lymph node—thyroid cancer	0.041	0.0754	CbGeAlD
Mimosine—SHMT1—thyroid gland—thyroid cancer	0.0409	0.0753	CbGeAlD
Mimosine—CCL2—thyroid gland—thyroid cancer	0.0379	0.0697	CbGeAlD
Mimosine—SHMT1—head—thyroid cancer	0.0363	0.0668	CbGeAlD
Mimosine—CCL2—head—thyroid cancer	0.0337	0.0619	CbGeAlD
Mimosine—SHMT1—lymph node—thyroid cancer	0.0254	0.0467	CbGeAlD
Mimosine—CCL2—Ectoderm Differentiation—TRIM33—thyroid cancer	0.0246	0.054	CbGpPWpGaD
Mimosine—CCL2—lymph node—thyroid cancer	0.0236	0.0433	CbGeAlD
Mimosine—CCL2—Ectoderm Differentiation—TCF7L1—thyroid cancer	0.0164	0.036	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CDK1—thyroid cancer	0.014	0.0307	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—LGALS3—thyroid cancer	0.0135	0.0296	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.0111	0.0243	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CALCB—thyroid cancer	0.0103	0.0225	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HIF1A—thyroid cancer	0.0102	0.0225	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—thyroid cancer	0.00972	0.0213	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00966	0.0212	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CDK1—thyroid cancer	0.00923	0.0202	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00848	0.0186	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—NRAS—thyroid cancer	0.00837	0.0184	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—SST—thyroid cancer	0.00723	0.0159	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—KRAS—thyroid cancer	0.0072	0.0158	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.00655	0.0144	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00624	0.0137	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—HRAS—thyroid cancer	0.00612	0.0134	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CCND1—thyroid cancer	0.00584	0.0128	CbGpPWpGaD
Mimosine—SHMT1—Disease—TRIM24—thyroid cancer	0.0057	0.0125	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—PTEN—thyroid cancer	0.00563	0.0124	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MINPP1—thyroid cancer	0.00562	0.0123	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.00538	0.0118	CbGpPWpGaD
Mimosine—SHMT1—Disease—CHST14—thyroid cancer	0.00536	0.0118	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CALCB—thyroid cancer	0.00527	0.0116	CbGpPWpGaD
Mimosine—SHMT1—Disease—TRIM33—thyroid cancer	0.00508	0.0111	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—thyroid cancer	0.00489	0.0107	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—thyroid cancer	0.00486	0.0107	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00485	0.0106	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NDUFA13—thyroid cancer	0.00478	0.0105	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—TSHR—thyroid cancer	0.00475	0.0104	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—KRAS—thyroid cancer	0.00459	0.0101	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CHST14—thyroid cancer	0.00449	0.00985	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—PTGS2—thyroid cancer	0.00425	0.00933	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.00421	0.00924	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—thyroid cancer	0.00408	0.00895	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTCH1—thyroid cancer	0.00404	0.00886	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—NRAS—thyroid cancer	0.00404	0.00886	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—thyroid cancer	0.00403	0.00884	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—thyroid cancer	0.00394	0.00864	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HRAS—thyroid cancer	0.0039	0.00856	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—thyroid cancer	0.00384	0.00843	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCND1—thyroid cancer	0.00384	0.00843	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—SST—thyroid cancer	0.0037	0.0081	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HPGD—thyroid cancer	0.00362	0.00794	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CALCA—thyroid cancer	0.00356	0.0078	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—KRAS—thyroid cancer	0.00348	0.00762	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—thyroid cancer	0.00344	0.00756	CbGpPWpGaD
Mimosine—SHMT1—Disease—TCF7L1—thyroid cancer	0.00339	0.00744	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CALCB—thyroid cancer	0.00311	0.00682	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.00295	0.00648	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TRIM33—thyroid cancer	0.00295	0.00647	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.00261	0.00572	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—thyroid cancer	0.00253	0.00555	CbGpPWpGaD
Mimosine—SHMT1—Disease—TPR—thyroid cancer	0.00248	0.00544	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKAR1A—thyroid cancer	0.00244	0.00536	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—TSHR—thyroid cancer	0.00244	0.00535	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.0024	0.00526	CbGpPWpGaD
Mimosine—SHMT1—Disease—MEN1—thyroid cancer	0.00233	0.00512	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TPR—thyroid cancer	0.00208	0.00456	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTCH1—thyroid cancer	0.00207	0.00455	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PRKAR1A—thyroid cancer	0.00205	0.00449	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TCF7L1—thyroid cancer	0.00197	0.00432	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SST—thyroid cancer	0.0019	0.00416	CbGpPWpGaD
Mimosine—SHMT1—Disease—CALCA—thyroid cancer	0.00186	0.00408	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CALCA—thyroid cancer	0.00183	0.004	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDK1—thyroid cancer	0.00168	0.00369	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CDK1—thyroid cancer	0.00165	0.00362	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC5A5—thyroid cancer	0.00156	0.00341	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TSHR—thyroid cancer	0.00144	0.00316	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKAR1A—thyroid cancer	0.00142	0.00311	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MEN1—thyroid cancer	0.00135	0.00297	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRG1—thyroid cancer	0.00135	0.00296	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RXRA—thyroid cancer	0.00131	0.00287	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTCH1—thyroid cancer	0.00122	0.00269	CbGpPWpGaD
Mimosine—SHMT1—Disease—TERT—thyroid cancer	0.00121	0.00266	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIF1A—thyroid cancer	0.00116	0.00254	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SST—thyroid cancer	0.00112	0.00246	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CALCA—thyroid cancer	0.00108	0.00236	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDK1—thyroid cancer	0.000976	0.00214	CbGpPWpGaD
Mimosine—SHMT1—Disease—BRAF—thyroid cancer	0.00096	0.00211	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARG—thyroid cancer	0.000826	0.00181	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRG1—thyroid cancer	0.000783	0.00172	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—thyroid cancer	0.000776	0.0017	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TERT—thyroid cancer	0.000703	0.00154	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—thyroid cancer	0.000676	0.00148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIF1A—thyroid cancer	0.000673	0.00148	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—thyroid cancer	0.000649	0.00142	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRAS—thyroid cancer	0.000603	0.00132	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NRAS—thyroid cancer	0.000593	0.0013	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—thyroid cancer	0.000566	0.00124	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BRAF—thyroid cancer	0.000557	0.00122	CbGpPWpGaD
Mimosine—SHMT1—Disease—KRAS—thyroid cancer	0.000519	0.00114	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KRAS—thyroid cancer	0.00051	0.00112	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—thyroid cancer	0.000441	0.000968	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—thyroid cancer	0.000434	0.000951	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—thyroid cancer	0.000407	0.000892	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—thyroid cancer	0.000392	0.000861	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—thyroid cancer	0.00039	0.000855	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—thyroid cancer	0.000383	0.00084	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRAS—thyroid cancer	0.00035	0.000768	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—thyroid cancer	0.000326	0.000716	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KRAS—thyroid cancer	0.000301	0.000661	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—thyroid cancer	0.000268	0.000587	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—thyroid cancer	0.000256	0.000562	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—thyroid cancer	0.000226	0.000496	CbGpPWpGaD
